Table 3

Adjusted Risks of 3-Year Adverse Clinical Outcomes in All BMI Groups Compared With Normal Weight Subjects

Underweight (n = 139) HR (95% CI)Normal Weight (n = 2,740)Overweight (n = 3,430) HR (95% CI)Obese (n = 1,920) HR (95% CI)Severely Obese (n = 1,191) HR (95% CI)
MACE1.35 (0.88–2.07), p = 0.171.000.88 (0.75–1.03), p = 0.110.91 (0.75–1.09), p = 0.310.84 (0.67–1.06), p = 0.14
Death2.20 (1.31–3.71), p = 0.0131.000.72 (0.55–0.94), p = 0.020.76 (0.55–1.05), p = 0.101.20 (0.83–1.75), p = 0.33
Cardiac death2.18 (1.07–4.44), p = 0.031.000.82 (0.57–1.17), p = 0.280.89 (0.58–1.37), p = 0.601.22 (0.73–2.04), p = 0.45
MI1.06 (0.25–4.43), p = 0.941.000.99 (0.64–1.52), p = 0.951.23 (0.77–1.98), p = 0.391.03 (0.58–1.81), p = 0.93
TLR1.22 (0.56–2.63), p = 0.611.001.23 (0.96–1.57), p = 0.091.00 (0.74–1.33), p = 0.980.86 (0.61–1.21), p = 0.38
Definite/probable ST2.00 (0.47–8.54), p = 0.351.001.11 (0.64–1.90), p = 0.711.47 (0.83–2.62), p = 0.180.83 (0.39–1.77), p = 0.63

Multivariable model based on age, diabetes, hypertension, smoking habit, hypercholesterolemia, family history of CAD, presentation (STEMI, NSTEMI, unstable angina, stable CAD), number of stents implanted, stent length, and B2/C lesions.

CI = confidence interval; HR = hazard ratio; MACE = major adverse cardiovascular event(s); ST = stent thrombosis; TLR = target lesion revascularization; other abbreviations as in Tables 1 and 2.